Avita Therapeutics Inc
Geschlossen
3.92 -0.51
Übersicht
Veränderung der Aktienkurses
24h
Min
3.81
Max
3.95
Einkommen | 1M -11M |
|---|---|
Verkäufe | 1.6M 19M |
EPS | -0.48 |
Gewinnspanne | -55.119 |
Angestellte | 226 |
EBITDA | 1.1M -8.6M |
Empfehlungen | Starkes Kaufsignal |
|---|---|
12-Monats-Prognose | +82.44% upside |
Nächstes Ergebnis | 6. Aug. 2026 |
|---|
Marktkapitalisierung | -5.8M 129M |
|---|---|
Vorheriger Eröffnungskurs | 4.43 |
Vorheriger Schlusskurs | 3.92 |
Avita Therapeutics Inc Chart
Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.
Über Avita Therapeutics Inc
AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.